{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_16364", "batch_size": 260, "batch_pos": 243, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 2, "answer": "no", "rationale": "The segment reports factual information about a project using neutral language.", "method": "llm_batch", "batch_id": "batch_2_16848", "batch_size": 260, "batch_pos": 242, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 3, "answer": "no", "rationale": "The verb 'begun scaling up' is not a moderate verb paired with significant impact scale.", "method": "llm_batch", "batch_id": "batch_3_17472", "batch_size": 260, "batch_pos": 233, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_11928", "batch_size": 260, "batch_pos": 232, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 5, "answer": "no", "rationale": "The segment reports a network scaling up testing, which is action/preparedness, but lacks explicit calming language or required keywords linking it to public safety.", "method": "llm_batch", "batch_id": "batch_5_17724", "batch_size": 260, "batch_pos": 230, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser used in conjunction with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_9812", "batch_size": 260, "batch_pos": 222, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_18116", "batch_size": 260, "batch_pos": 222, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 8, "answer": "yes", "rationale": "Describes scaling up testing (surveillance/capability): 'has begun scaling up H5-specific testing'.", "method": "llm_batch", "batch_id": "batch_8_18340", "batch_size": 260, "batch_pos": 198, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
